![]() |
|
|
Vol. 27, Issue 6, 667-673, June 1999
College of Pharmacy, Seoul National University (S.G.K., M.K.K.,
N.D.K.), Seoul, Korea; and College of Pharmacy, Duksung Women's
University (S.G.K., M.K.C., S.H.C., H.J.K.)
The expression of hepatic microsomal epoxide hydrolase (mEH) and
glutathione S-transferases (GSTs) by
2-(allylthio)pyrazine (2-AP), an experimental chemopreventive agent,
was investigated in rats. Northern blot analysis revealed that 2-AP
caused increases in mEH, rGSTA2/3/5, and rGSTM1/2 mRNA levels. mEH and
rGSTA2 proteins were also induced. Molecular basis of the enzyme
induction by 2-AP was studied in comparison with oltipraz (Olt). Rats
exposed to buthionine sulfoximine, a GSH-depleting agent, before
treatment with either 2-AP or Olt exhibited greater increases in the
mRNA levels than the individual treatment. Conversely, increases of the
mRNAs were prevented by cysteine treatment, indicating that metabolic
intermediates or reactive oxygens produced from the agents could be
reduced by cysteine. Gel shift analysis revealed that nuclear
factor-
B, which is associated with the altered cellular redox
state, was not activated by the agents. Effects of these agents on the
breakage of
x-174 DNA were compared in vitro. 2-AP effectively
reduced the conversion of supercoiled DNA to the open circular form
induced by benzenetriol and prevented benzenetriol- and iron-catalyzed
degradation of DNA, whereas Olt failed to prevent strand breakage of
DNA. These results provided evidence that: 1) 2-AP was effective in
elevating the hepatic mEH and GST gene expression in rats, which might
be mediated with the production of reactive oxygen species; 2) nuclear
factor-
B activation was not involved in the induction of the
detoxifying enzymes by either 2-AP or Olt in spite of their production
of reactive oxygens in vivo; and 3) the antioxidant effect of 2-AP in
vitro differed from that of Olt.
This article has been cited by other articles:
![]() |
D. J. Auyeung, F. K. Kessler, and J. K. Ritter Mechanism of Rat UDP-Glucuronosyltransferase 1A6 Induction by Oltipraz: Evidence for a Contribution of the Aryl Hydrocarbon Receptor Pathway Mol. Pharmacol., January 1, 2003; 63(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Lamb and M. R. Franklin Early Events in the Induction of Rat Hepatic UDP-Glucuronosyltransferases, Glutathione S-Transferase, and Microsomal Epoxide Hydrolase by 1,7-Phenanthroline: Comparison with Oltipraz, tert-Butyl-4-hydroxyanisole, and tert-Butylhydroquinone Drug Metab. Dispos., September 1, 2000; 28(9): 1018 - 1023. [Abstract] [Full Text] |
||||